Corneal edema involves fluid accumulation in the cornea, leading to cloudiness and vision impairment. The market is growing due to an aging population and increasing cataract and glaucoma surgeries.

New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical ...

Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...

Thermo Fisher Scientific Inc. has opened its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in ...

Fanconi Anemia Market Growth Driven by Genetic Research and Healthcare Investments**Fanconi Anemia (FA) is a rare genetic disorder impacting bone marrow's ability to produce blood cells, leading to ...

Chronic diseases once meant a lifetime of management. But a new generation of cell and gene therapies is challenging that paradigm. Markets are responding. The global cell and gene therapy market is ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated a new RNA-based therapeutic strategy that ...

Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such ...

At the Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs ...

Cincinnati Children's dedicated a new research center in Sharonville to finding treatments for patients with cancer, blood ...

A rare disease that has cut off children from the outside world now potentially has a cure. A clinical trial to treat severe ...